|
Should prophylaxis be used in adolescent and adult patients
with severe haemophilia? An European survey of practice and
outcome data
M. RICHARDS,* C. ALTISENT, A. BATOROVA, H. CHAMBOST,§ G. DOLAN,–
P. DE MOERLOOSE,** M. FRAGA, C. HERMANS, A. KARAFOULIDOU,§§ R. KLAMROTH,––
R. LASSILA*** and C. ROTHSCHILD *ON BEHALF OF THE EUROPEAN HAEMOPHILIA
THERAPY STANDARDISATION BOARD
*Paediatric Haematology Department, Children’s Day Hospital, St James University Hospital, Leeds, UK; Unitat
d’Hemofilia, Hospital Vall d’Hebron, Barcelona, Spain; National Haemophilia Centre, Department of Hematology and
Blood Transfusion, University Hospital, Bratislava, Slovak Republic; §Service d He´matologie Pe´diatrique Hoˆ pital de la
Timone, Marseille, France; –Queen’s Medical Centre, University Hospital, Nottingham, UK; **Hoˆ pitaux Universitaires de
Gene`ve, Unite´ d’He´mostase, Geneva, Switzerland; Hospital de Sao Joao, Porto, Portugal; Cliniques Universitaires St
Luc, Haemostasis Department, Bruxelles,Belgium; §§Laikon General Hospital, Athens, Greece; ––Vivantes – Klinikum in
Friedrichhain Klinik fuer Innere Medizin Haemophiliezentrum, Berlin, Germany; ***University Hospital Helsinki Unit of
Coagulation Disorders, Helsinki, Finland; and Centre d He´mophilie F. Josso, Hoˆ pital Necker, Paris, France
原文下载：重度血友病患者是否应该进行预防治疗
|
